Skip to main content

SIGA Technologies, Inc.

corporate_fare Company Profile

SIGA Technologies, Inc.

SIGA·NASDAQ·Life Sciences·CIK 0001010086

SIGA Technologies, Inc. is a commercial-stage pharmaceutical company that sells its lead product, TPOXX®, to the U.S. Government and international governments, including government-affiliated entities. In some international markets, the company may sell TPOXX® through a distributor. TPOXX® is an antiviral drug used to treat human smallpox disease caused by the variola virus. The company sells both an oral formulation and an intravenous formulation of TPOXX®. The oral formulation of TPOXX® was approved by the United States Food & Drug Administration (FDA) on July 13, 2018, for the treatment of smallpox. SIGA has been supplying oral TPOXX® to the U.S. Strategic National Stockpile since 2013. The intravenous formulation of TPOXX® was approved by the FDA on May 18, 2022, for the treatment of smallpox and is sold to the U.S. Government. Beyond FDA approval, oral TPOXX® (tecovirimat) has also received regulatory approval from the European Medicines Agency (EMA), Health Canada, the Medicines and Healthcare Products Regulatory Agency (MHRA) of the United Kingdom, and the Japanese Pharmaceuticals and Medical Devices Agency (PMDA). The EMA, MHRA, and PMDA approved oral TPOXX® for the treatment of smallpox, monkeypox (mpox), cowpox, and vaccinia complications following smallpox vaccination. Health Canada approved TPOXX® for the treatment of smallpox. The EMA and MHRA authorized TPOXX® under "exceptional circumstances" using the brand name Tecovirimat-SIGA, due to the rarity of smallpox and other orthopoxviruses, which limited the ability to gather complete efficacy and safety data through standard clinical studies. These authorizations require specific post-approval data collection and annual reassessments.

SIGA Technologies, Inc. (NASDAQ:SIGA) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 14 items for SIGA at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-09, rated 7/10. Across its 14 most recent items scored 7 or higher, the top rating is 9/10, with 4 rated 8 or above. Recent SEC coverage for SIGA spans 10-Q, 8-K, DEFA14A, DEF 14A.

Recent high-impact activity:

  • SIGA 10-Q: Q3 Revenue $1.3M, Net Loss $2.9M, Cash $116.4M as BARDA Follow-On Awaited
  • Q3 Revenue Collapses to $1.3M as BARDA Contract Winds Down; CSO Retires
  • SIGA Q2 Revenue Halves as BARDA Contract Winds Down; Cash Drops to $118M
  • Stockholders Approve 6.5 Million Share Increase for Incentive Plan
  • SIGA Declares Massive $0.60 Special Dividend, Plans Q2-Q3 TPOXX Shipments

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$94.57M
Net Income
$23.28M
Diluted EPS
$0.32
Op. Cash Flow
$43.47M
Free Cash Flow
$43.12M
Gross Profit
$64.87M
Operating Income
$23.7M
Cash & Equivalents
$154.97M
Debt / Equity
0.00×
Net Margin
24.6%
Shares Outstanding
71.61M sh
Source: 10-K · filed 2026-03-10 · accession 0001437749-26-007557

Short Interest & Short Volume

7.76 days to cover

FINRA reported short interest of 3,567,607 shares in SIGA as of the October 30, 2026 settlement, a 0.1% increase from the prior period — about 7.8 days to cover at its recent average daily volume. On November 20, 2026, 53.5% of SIGA volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)3,567,607 shares as of October 30, 2026
Change vs prior period▲ 0.1%
Days to cover7.76 at avg daily volume of 459,793
Daily short volume (FINRA facilities)53.5% of 349,759 shares on November 20, 2026
5-day average short volume49.5%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with S →
$2.42 +0.79% today
52-week range · as of 2026-11-09 $2.42 – $7.43
Market cap
$172.45M
Volume
788.3K (1.4× avg)
3-mo avg 548.1K
Live data · 2026-11-21 18:06 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed SIGA - Latest Insights

SIGA
Nov 09, 2026, 4:51 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $3.26
Real-time Price: $2.42 info
Change: -$0.8411 (-26%) info
Market Cap: $172.452M info
SIGA
Nov 09, 2026, 4:01 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $3.26
Real-time Price: $2.42 info
Change: -$0.8411 (-26%) info
Market Cap: $172.452M info
SIGA
Aug 06, 2026, 4:46 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $3.25
Real-time Price: $2.42 info
Change: -$0.8311 (-26%) info
Market Cap: $172.452M info
SIGA
Jun 10, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $4.36
Real-time Price: $2.42 info
Change: -$1.94 (-45%) info
Market Cap: $172.452M info
SIGA
May 08, 2026, 4:06 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $4.88
Real-time Price: $2.42 info
Change: -$2.46 (-50%) info
Market Cap: $172.452M info
SIGA
May 08, 2026, 4:01 PM EDT
Filing Type: DEFA14A
Importance Score:
7
Price at Filing: $4.80
Real-time Price: $2.42 info
Change: -$2.38 (-50%) info
Market Cap: $172.452M info
SIGA
May 07, 2026, 4:48 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $4.60
Real-time Price: $2.42 info
Change: -$2.18 (-47%) info
Market Cap: $172.452M info
SIGA
May 07, 2026, 4:08 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.60
Real-time Price: $2.42 info
Change: -$2.18 (-47%) info
Market Cap: $172.452M info
SIGA
May 07, 2026, 4:07 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $4.72
Real-time Price: $2.42 info
Change: -$2.30 (-49%) info
Market Cap: $172.452M info
SIGA
Apr 28, 2026, 4:02 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $4.59
Real-time Price: $2.42 info
Change: -$2.17 (-47%) info
Market Cap: $172.452M info
SIGA
Mar 26, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $5.44
Real-time Price: $2.42 info
Change: -$3.02 (-56%) info
Market Cap: $172.452M info
SIGA
Mar 26, 2026, 4:01 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $5.21
Real-time Price: $2.42 info
Change: -$2.79 (-54%) info
Market Cap: $172.452M info
SIGA
Mar 11, 2026, 4:04 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $5.48
Real-time Price: $2.42 info
Change: -$3.06 (-56%) info
Market Cap: $172.452M info
SIGA
Mar 10, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.65
Real-time Price: $2.42 info
Change: -$3.23 (-57%) info
Market Cap: $172.452M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets